MSF Field Research > 1 Published Research and Commentary > TB > Linezolid for multidrug-resistant tuberculosis.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/269593
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
Cox H et al Linezolid for multidrug-resistant - Lancet ID 13-01 2013-01.pdf40KbAdobe PDF

Title: Linezolid for multidrug-resistant tuberculosis.
Authors: Cox, Helen
Ford, Nathan
Hughes, Jennifer
Goemaere, Eric
Citation: Linezolid for multidrug-resistant tuberculosis. 2013, 13 (1):16 Lancet Infect Dis
Journal: The Lancet Infectious Diseases
Issue Date: Jan-2013
URI: http://hdl.handle.net/10144/269593
DOI: 10.1016/S1473-3099(12)70299-2
PubMed ID: 23257228
Language: en
ISSN: 1474-4457
Rights: Published by Elsevier Reproduced on this site with permission of Elsevier Ltd. Please see http://www.thelancet.com/journals/laninf for further relevant comment.
Appears in topics: TB

Related articles on PubMed
bullet
Linezolid for multidrug-resistant tuberculosis.
Chang KC, Leung CC, Daley CL
2012 Jul
bullet
bullet
bullet
bullet
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Sotgiu G, Centis R, D'Ambrosio L, Spanevello A, Migliori GB, International Group for the study of Linezolid
2013 Jul
See all 104 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Aug 29, 2014